Administration and Biostatistics

行政管理和生物统计学

基本信息

  • 批准号:
    10217983
  • 负责人:
  • 金额:
    $ 8.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-17 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

The principal goal of the Administrative and Biostatistics Core (Core A) is to provide the essential operational plan and organizational structure to facilitate the continued success of the U19. This will be accomplished by coordinating both scientific and logistical issues for the individual Projects and the Transplant Pathology and Tissue Imaging Core (Core B), their interactions to enhance conceptual unity and Program synergy and the U19 as a whole. The Core will coordinate communication and scientific meetings between the Program Director (PD), Project Leaders (PLs), Co-Investigators and the Leader of Core B to facilitate scientific collaboration, project interaction, and data sharing,- each important goals of the U19. The Core will also co- ordinate data and statistical input for each of the Projects through a faculty biostatistician. It will provide logistical assistance for preparation of reports (including annual milestone reports), compliance and regulatory issues, grant renewal, and abstract and manuscript submissions. Also, by providing financial oversight, the Core will maximize the responsible and efficient use and allocation of funds, thus fulfilling obligations to the University of Pittsburgh and the NIAID. In executing these functions, the Core will also allow the PD, PLs, Core B Leader and Co-Investigators more time to address their research goals. An additional important function of the Core will be to co-ordinate communication with the NIAID and NHPCSG Steering Committee.
行政和生物统计核心(核心A)的主要目标是提供基本的 运营计划和组织结构,以促进U19的持续成功。这将是 通过协调各个项目和移植的科学和后勤问题来完成 病理学和组织成像核心(核心B),其相互作用,以加强概念统一性和程序 #21419;,以及U19作为一个整体。核心将协调各组织之间的交流和科学会议, 项目总监(PD)、项目负责人(PL)、合作研究者和核心B负责人,以促进科学研究 协作、项目互动和数据共享--这是U19的重要目标。核心也将共同- 通过生物统计学家协调每个项目的数据和统计输入。它将提供 为编写报告(包括年度里程碑报告)、合规和监管提供后勤援助 问题,赠款续期,摘要和手稿提交。此外,通过提供财务监督, 核心将尽可能负责任和有效地使用和分配资金,从而履行对 匹兹堡大学和NIAID。在执行这些功能时,核心还将允许PD、PL、核心 B负责人和合作研究者有更多的时间来解决他们的研究目标。的另一个重要功能 核心将协调与NIAID和NHPCSG指导委员会的沟通。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Angus W Thomson其他文献

Transplant Tolerance Induction: Insights From the Liver
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
  • 作者:
    Helong Dai;Yawen Zheng;Angus W Thomson;Natasha M Rogers
  • 通讯作者:
    Natasha M Rogers
Organ transplantation—how much of the promise has been realized?
器官移植——兑现了多少承诺?
  • DOI:
    10.1038/nm1251
  • 发表时间:
    2005-06-03
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Robert I Lechler;Megan Sykes;Angus W Thomson;Laurence A Turka
  • 通讯作者:
    Laurence A Turka

Angus W Thomson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Angus W Thomson', 18)}}的其他基金

Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
  • 批准号:
    9924470
  • 财政年份:
    2018
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
  • 批准号:
    10153679
  • 财政年份:
    2018
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
活体肾移植受者的调节性树突状细胞治疗
  • 批准号:
    10396484
  • 财政年份:
    2018
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
  • 批准号:
    10518430
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
  • 批准号:
    9927591
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
  • 批准号:
    9329522
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP肾移植中的调节性免疫细胞治疗、耐受性促进及潜在机制
  • 批准号:
    10217982
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Administration and Biostatistics
行政管理和生物统计学
  • 批准号:
    10596902
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulatory dendritic cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
NHP 肾移植中的调节性树突状细胞治疗、耐受性促进及潜在机制
  • 批准号:
    10596904
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
  • 批准号:
    9372923
  • 财政年份:
    2017
  • 资助金额:
    $ 8.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了